Skip to main content
  • EuroPCR: Drug-Coated Stent Better for ACS When Bleed Risk High “BMS can no longer be recommended in these patients”

    PARIS — Patients with acute coronary syndrome (ACS) and high bleeding risk do better with a drug-coated stent than a bare metal stent (BMS), a LEADERS FREE substudy found.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details